ArticleCell reports. Medicine2026

Cancer cell-derived sialylated IgG interacting with Siglec-7/9/10 is a potential immunotherapeutic target in pancreatic cancer.

Shenghua Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.